Fig 1.
Recruitment and randomized allocation group from the CONSORT 2010 flow diagram.
Fig 2.
The overall flow of research.
Table 1.
AT intervention program.
Table 2.
The brain function quotient.
Table 3.
General characteristics of the control and experimental groups.
Table 4.
Ranked analysis of covariance for NK cells, and cortisol.
Fig 3.
Changes in participants’ SAP expression level before and after AT.
(A, B) Western blotting repeated experiments were conducted on four randomly selected participants in the control and experimental groups.
- Control group pre- test: A, B
- Control group post- test: A’, B’
- Experimental group pre- test: C, D
- Experimental group post- test: C’, D’.
(C) Results of Wilcoxon’s signed-rank test of Western blotting results of the control group (n = 15), and experimental group (n = 20)
Control group: JNK (Z = -1.022, p = 0.307), p-JNK (Z = -1.079, p = 0.281), and Elk-1 (Z = -2.613, p = 0.009)
Experimental group: JNK (Z = -2.613, p = 0.009), p-JNK (Z = -2.501, p = 0.012), and Elk-1 (Z = -2.651, p = 0.008). ** p <0.01, * p <0.05.
Table 5.
Means and Wilcoxon’s signed-rank test comparisons for study variables.
Table 6.
Means and Wilcoxon’s signed-rank comparisons for MMPI-2 (validity scales and clinical scales).